BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33822903)

  • 1. Feasible TLC-Spectro-Densitometry Technique for Simultaneous Determination of Two Hepatitis C Antiviral Drugs, Sofosbuvir and Simeprevir: Application to Combined Pharmaceutical Dosage Forms and Human Plasma.
    Mohammed BS; Derayea SM; Hamad AE
    J Chromatogr Sci; 2021 May; 59(6):576-583. PubMed ID: 33822903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis.
    Abo-Zeid MN; El-Gizawy SM; Atia NN; El-Shaboury SR
    J Pharm Biomed Anal; 2018 Jul; 156():358-365. PubMed ID: 29753282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPLC-UV and TLC-Densitometry Methods for Simultaneous Determination of Sofosbuvir and Daclatasvir: Application to Darvoni® Tablet.
    Fayed AS; Hegazy MA; Kamel EB; Eissa MS
    J Chromatogr Sci; 2022 Jul; 60(6):606-612. PubMed ID: 34355234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress stability study of simeprevir, a hepatitis C virus inhibitor, using feasible TLC-spectro-densitometry: application to pharmaceutical dosage form and human plasma.
    Mohammed BS; Hamad AE; Derayea SM
    RSC Adv; 2020 Jun; 10(36):21100-21107. PubMed ID: 35518774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thin-layer chromatography/fluorescence detection approach for sensitive and selective determination of hepatitis C virus antiviral (velpatasvir): application to human plasma.
    Derayea SM; Abdel-Lateef MA; Omar MA; Ali R
    Luminescence; 2020 Nov; 35(7):1048-1055. PubMed ID: 32350964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a highly sensitive high-performance thin-layer chromatography method for the screening and simultaneous determination of sofosbuvir, daclatasvir, and ledipasvir in their pure forms and their different pharmaceutical formulations.
    Saraya RE; Elhenawee M; Saleh H
    J Sep Sci; 2018 Sep; 41(18):3553-3560. PubMed ID: 30048040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study.
    Ferrari D; Bagaglio S; Raso M; Galli L; Premaschi S; Messina E; Morsica G; Locatelli M; Uberti-Foppa C; Hasson H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():1-7. PubMed ID: 31055190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study.
    Zidan DW; Hassan WS; Elmasry MS; Shalaby AA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():73-81. PubMed ID: 29660665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New, simple and sensitive HPTLC method for simultaneous determination of anti-hepatitis C sofosbuvir and ledipasvir in rabbit plasma.
    El-Gizawy SM; El-Shaboury SR; Atia NN; Abo-Zeid MN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():432-439. PubMed ID: 29945107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of TLC-densitometric method for simultaneous determination of two binary antihypertensive mixtures containing felodipine in fixed dose combinations.
    Mohamed AM; Omar MA; Hammad MA; Mohamed AA
    Biomed Chromatogr; 2016 Feb; 30(2):200-7. PubMed ID: 26096877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits.
    Atia NN; El-Shaboury SR; El-Gizawy SM; Abo-Zeid MN
    J Pharm Biomed Anal; 2018 Sep; 158():88-93. PubMed ID: 29864695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms.
    Ezzeldin E; Abo-Talib NF; Tammam MH; Asiri YA; Amr AEE; Almehizia AA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33050433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Determination of Synthesized Genotoxic Impurities in Nifuroxazide Capsules by Validated Chromatographic Methods.
    Abdelwahab NS; Ali NW; Zaki MM; Abdelkawy M; El-Saadi MT
    J AOAC Int; 2018 Mar; 101(2):385-393. PubMed ID: 28762331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantification of simeprevir sodium: A hepatitis C protease inhibitor in binary and ternary mixtures with sofosbuvir and/or ledipasvir utilizing direct and H-point standard addition strategies.
    Mohamed SH; Issa YM; Salim AI
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Mar; 210():290-297. PubMed ID: 30469132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of sofosbuvir with two co-administered drugs; paracetamol and DL-methionine by two chromatographic methods. Application to a pharmacokinetic study.
    Fares MY; Abdelwahab NS; Abdelrahman MM; Abdel-Rahman HM
    Bioanalysis; 2019 Mar; 11(5):349-364. PubMed ID: 30873855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical processing of absorption as green smart spectrophotometric methods for concurrent assay of hepatitis C antiviral drugs, Sofosbuvir and Simeprevir: application to combined pharmaceutical dosage forms and evaluation of the method greenness.
    Derayea SM; Abu-Hassan AA; Hamad AA; Eltoukhi WE; Hamad AE; Mohammed BS
    BMC Chem; 2023 Jul; 17(1):75. PubMed ID: 37452429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micellar high performance liquid chromatographic method for separation and validation of two anti-hepatitis C- virus drugs in pure form, human plasma and human urine.
    Hassan WS; Elmasry MS; Shalaby A; El-Sayed HM; Zidan DW
    Ann Pharm Fr; 2020 May; 78(3):217-229. PubMed ID: 32253022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microenvironment improvement protocol for the sensitive spectrofluorimetric determination of an hepatitis C virus antiviral (Simeprevir): application to human plasma.
    Derayea SM; A El Hamd M; Ali S; Samir E
    Luminescence; 2020 May; 35(3):393-399. PubMed ID: 31849179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between core-shell and totally porous particle stationary phases for fast and green LC determination of five hepatitis-C antiviral drugs.
    Ibrahim AE; Hashem H; Elhenawee M; Saleh H
    J Sep Sci; 2018 Apr; 41(8):1734-1742. PubMed ID: 29297968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micelle sensitized synchronous spectrofluorimetric approaches for the simultaneous determination of simeprevir and ledipasvir: Application to pharmaceutical formulations and human plasma.
    Hamad AE; Mohammed BS; Derayea SM; El-Malla SF
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Oct; 239():118471. PubMed ID: 32474370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.